Form 4 for ALKS Alkermes plc.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001520262-26-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-25 | 2026-02-23 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | — | +7,689 | 93.0K | +9% | — |
| D | 2026-02-25 | 2026-02-23 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | F - Tax | $32.19 | -3,414 | 89.6K | -4% | -$109.9K |
| D | 2026-02-25 | 2026-02-23 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | — | -7,689 | 7,690 | -50% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-23 | M | A | 7,689 | — | 92,986 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. |
| 2 | Common | Ordinary Shares | 2026-02-23 | F | D | 3,414 | $32.19 | 89,572 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit Award | 2026-02-23 | M | D | 7,689 | — | 7,690 | D | — · — to — | 7,689 Ordinary Shares | (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F2) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. |